Total Payments
$207,711
2024 Payments
$15,510
Companies
52
Transactions
1,441
Medicare Patients
21,115
Medicare Billing
$3.2M
Payment Breakdown by Category
Other$167,023 (80.4%)
Food & Beverage$31,725 (15.3%)
Travel$8,504 (4.1%)
Consulting$450.00 (0.2%)
Education$9.60 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $167,023 | 117 | 80.4% |
| Food and Beverage | $31,725 | 1,288 | 15.3% |
| Travel and Lodging | $8,504 | 34 | 4.1% |
| Consulting Fee | $450.00 | 1 | 0.2% |
| Education | $9.60 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69,399 | 176 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $55,431 | 113 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $38,504 | 161 | $0 (2024) |
| Esperion Therapeutics, Inc. | $10,506 | 24 | $0 (2024) |
| Lilly USA, LLC | $7,418 | 11 | $0 (2024) |
| Medtronic Vascular, Inc. | $5,462 | 92 | $0 (2020) |
| ABIOMED | $4,143 | 126 | $0 (2024) |
| CVRx, Inc. | $3,259 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,635 | 179 | $0 (2024) |
| Medtronic, Inc. | $2,111 | 127 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,510 | 198 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,705) |
| 2023 | $17,698 | 205 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,386) |
| 2022 | $30,590 | 202 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,136) |
| 2021 | $83,075 | 235 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28,793) |
| 2020 | $45,997 | 172 | AstraZeneca Pharmaceuticals LP ($27,348) |
| 2019 | $6,560 | 148 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($4,384) |
| 2018 | $6,665 | 183 | Medtronic Vascular, Inc. ($4,342) |
| 2017 | $1,616 | 98 | Medtronic Vascular, Inc. ($297.67) |
All Payment Transactions
1,441 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/27/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/27/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/20/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $37.25 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/16/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $38.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Obesity | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/15/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $2.18 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,425.00 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/25/2024 | Medtronic, Inc. | REVEAL LINQ (Device) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 5,829 | 14,414 | $2.5M | $881,833 |
| 2022 | 43 | 5,807 | 14,409 | $2.5M | $919,290 |
| 2021 | 37 | 5,056 | 12,113 | $2.2M | $767,718 |
| 2020 | 48 | 4,423 | 10,809 | $1.7M | $656,694 |
Total Patients
21,115
Total Services
51,745
Medicare Billing
$3.2M
Procedure Codes
186
All Medicare Procedures & Services
186 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 81 | 81 | $541,200 | $236,192 | 43.6% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 91 | 92 | $230,000 | $96,156 | 41.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 115 | 119 | $127,050 | $70,759 | 55.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 307 | 2,071 | $103,550 | $48,949 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 393 | 561 | $77,510 | $45,869 | 59.2% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 26 | 26 | $81,120 | $43,297 | 53.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 311 | 319 | $349,400 | $41,600 | 11.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 305 | 2,076 | $124,560 | $37,276 | 29.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 676 | 693 | $171,138 | $33,615 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 368 | 508 | $99,958 | $31,076 | 31.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 137 | 546 | $40,950 | $24,372 | 59.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 165 | 190 | $34,960 | $22,906 | 65.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 118 | 620 | $43,400 | $21,084 | 48.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 105 | 574 | $34,440 | $16,249 | 47.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 107 | 461 | $34,575 | $14,784 | 42.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 180 | $21,960 | $10,489 | 47.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 552 | 903 | $74,046 | $8,369 | 11.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 58 | 63 | $45,297 | $7,922 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $21,096 | $7,617 | 36.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 134 | 135 | $45,360 | $6,669 | 14.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 45 | 45 | $16,830 | $6,593 | 39.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 73 | $13,140 | $6,340 | 48.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 47 | $12,643 | $6,018 | 47.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 52 | 53 | $14,681 | $5,077 | 34.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 17 | 17 | $31,552 | $5,014 | 15.9% |
About Dr. Donny Stokes, MD
Dr. Donny Stokes, MD is a Cardiovascular Disease healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821290990.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donny Stokes, MD has received a total of $207,711 in payments from pharmaceutical and medical device companies, with $15,510 received in 2024. These payments were reported across 1,441 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($167,023).
As a Medicare-enrolled provider, Stokes has provided services to 21,115 Medicare beneficiaries, totaling 51,745 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 186 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Jackson, MS
- Active Since 06/01/2007
- Last Updated 01/11/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1821290990
Products in Payments
- JARDIANCE (Drug) $76,619
- FARXIGA (Drug) $54,845
- LifeVest (Device) $38,504
- NEXLIZET (Drug) $9,550
- Impella (Device) $4,143
- Barostim Neo System (Device) $3,259
- ENTRESTO (Drug) $1,692
- SelectSecure (Device) $1,526
- Reveal LINQ (Device) $1,295
- Repatha (Biological) $1,194
- REVEAL LINQ (Device) $1,041
- XARELTO (Drug) $1,009
- NEXLETOL (Drug) $956.37
- LEQVIO (Drug) $943.73
- VERQUVO (Drug) $745.19
- BRILINTA (Drug) $616.95
- LINQ II (Device) $583.24
- ELIQUIS (Drug) $562.97
- Corlanor (Drug) $542.81
- WATCHMAN Access System (Device) $429.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Jackson
Javed Butler, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $4.7M
Cardiovascular Disease $4.7M
Mr. Rajendra Mehta, Md, MD
Cardiovascular Disease — Payments: $358,105
Cardiovascular Disease $358,105
William Crowder, M.d, M.D
Cardiovascular Disease — Payments: $328,962
Cardiovascular Disease $328,962
Dr. Adeyinka Agbetoyin, Md, MD
Cardiovascular Disease — Payments: $84,165
Cardiovascular Disease $84,165
Dr. Kenny Charn, M.d, M.D
Cardiovascular Disease — Payments: $60,472
Cardiovascular Disease $60,472
Elliot Kurban, Md, MD
Cardiovascular Disease — Payments: $57,215
Cardiovascular Disease $57,215